journal article·2014Open access

Cytotoxicity of nanoscaled metal–organic frameworks

Cristina Tamames-Tabar, Denise Cunha, Edurne Imbuluzqueta, Florence Ragon, Christian Serre, María J. Blanco-Prieto, Patricia Horcajada

J. Mater. Chem. B· Volume 2· Issue 3

Abstract

A series of fourteen porous Metal–Organic Frameworks (MOFs) with different compositions (Fe, Zn, and Zr; carboxylates or imidazolates) and structures have been successfully synthesised at the nanoscale and fully characterised by XRPD, FTIR, TGA, N2 porosimetry, TEM, DLS and ζ-potential. Their toxicological assessment was performed using two different cell lines: human epithelial cells from foetal cervical carcinoma (HeLa) and murine macrophage cell line (J774). It appears that MOF nanoparticles (NPs) exhibit low cytotoxicity, comparable to those of other commercialised nanoparticulate systems, the less toxic being the Fe carboxylate and the more toxic being the zinc imidazolate NPs. The cytotoxicity values, higher in J774 cells than in HeLa cells, are mainly function of their composition and cell internalisation capacity. Finally, cell uptake of one of the most relevant Fe-MOF-NPs for drug vectorisation has been investigated by confocal microscopy studies, and indicates a faster kinetics of cell penetration within J774 compared to HeLa cells.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Metal-Organic Frameworks: Synthesis and Applications · MicroRNA in disease regulation · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (60)

Show source-provided references
1. Chem. Soc. Rev., 2009, 38, 1201
2. Chem. Rev., 2012, 112, 673
3. See special issue: Acc. Chem. Res., 2005, 38, 215
4. Horcajada · Chem. Rev. · 2012 · 112 · 123210.1021/cr200256v ↗
5. Rieter · J. Am. Chem. Soc. · 2006 · 128 · 902410.1021/ja0627444 ↗
6. Horcajada · Angew. Chem., Int. Ed. · 2006 · 45 · 597410.1002/anie.200601878 ↗
7. Gaudin · Microporous Mesoporous Mater. · 2012 · 157 · 12410.1016/j.micromeso.2011.06.011 ↗
8. Xiao · J. Am. Chem. Soc. · 2007 · 129 · 120310.1021/ja066098k ↗
9. Carne · Chem. Soc. Rev. · 2011 · 40 · 29110.1039/C0CS00042F ↗
10. Gómez-Herrero · Adv. Mater. · 2011 · 23 · 531110.1002/adma.201101952 ↗
11. Horcajada · Nat. Mater. · 2010 · 9 · 17210.1038/nmat2608 ↗
12. Demessence · Chem. Commun. · 2009 · 714910.1039/b915011k ↗
13. Taylor-Pashow · J. Am. Chem. Soc. · 2009 · 131 · 1426110.1021/ja906198y ↗
14. Regulation (EC) no. 1907/2006; OJ L 396 of 30 December 200610.1192/pb.30.10.396 ↗
15. Chalati · Nanomedicine · 2011 · 6 · 168310.2217/nnm.11.69 ↗
16. Taylor-Pashow · J. Am. Chem. Soc. · 2009 · 131 · 1426110.1021/ja906198y ↗
17. Rieter · J. Am. Chem. Soc. · 2008 · 130 · 1158410.1021/ja803383k ↗
18. Huxford · Chem. Sci. · 2012 · 3 · 19810.1039/C1SC00499A ↗
19. Baati · Chem. Sci. · 2013 · 4 · 159710.1039/c3sc22116d ↗
20. Horcajada · Chem. Commun. · 2007 · 282010.1039/B704325B ↗
21. Férey · Science · 2005 · 309 · 204010.1126/science.1116275 ↗
22. Liu · Angew. Chem., Int. Ed. · 2007 · 46 · 327810.1002/anie.200604306 ↗
23. Dhakshinamoorthy · Catal. Sci. Technol. · 2012 · 2 · 32410.1039/C2CY00376G ↗
24. Cavka · J. Am. Chem. Soc. · 2008 · 130 · 1385010.1021/ja8057953 ↗
25. Serre · Science · 2007 · 315 · 182810.1126/science.1137975 ↗
26. Chalati · J. Mater. Chem. · 2011 · 21 · 222010.1039/C0JM03563G ↗
27. Horcajada · J. Am. Chem. Soc. · 2011 · 133 · 1783910.1021/ja206936e ↗
28. Horcajada · J. Am. Chem. Soc. · 2011 · 133 · 1783910.1021/ja206936e ↗
29. Demessence · J. Mater. Chem. · 2010 · 20 · 767610.1039/c0jm00500b ↗
30. Mosmann · J. Immunol. Methods · 1983 · 65 · 5510.1016/0022-1759(83)90303-4 ↗
31. Cunha · J. Mater. Chem. B · 2013 · 1 · 110110.1039/c2tb00366j ↗
32. P. Horcajada , private communication
33. Sumida · Hum. Exp. Toxicol. · 2011 · 30 · 170110.1177/0960327111399325 ↗
34. Rutherford · Eukaryotic Cell · 2004 · 3 · 110.1128/EC.3.1.1-13.2004 ↗
35. L. L. Brunton , D. K.Blumenthal, I. L. O.Buxton and K.Parker, Goodman & Gilman's Manual of Pharmacology and Therapeutics, McGraw-Hill Professional, USA, 2008
36. Borovanský · Chem.-Biol. Interact. · 1989 · 69 · 27910.1016/0009-2797(89)90085-9 ↗
37. Wahab · J. Biol. Inorg. Chem. · 2011 · 16 · 43110.1007/s00775-010-0740-0 ↗
38. Karlsson · Chem. Res. Toxicol. · 2008 · 21 · 172610.1021/tx800064j ↗
39. Brunner · Environ. Sci. Technol. · 2006 · 40 · 437410.1021/es052069i ↗
40. Mahmoudi · J. Phys. Chem. C · 2009 · 113 · 957310.1021/jp9001516 ↗
41. Nuñez · Biol. Res. · 2000 · 33 · 13310.4067/S0716-97602000000200013 ↗
42. M. C. R. Symons and J. M. C.Gutteridge, Free Radicals and Iron: Chemistry, Biology and Medicine, Oxford University Press, Oxford, 199810.1093/oso/9780198558927.001.0001 ↗
43. Mallikarjun · Free Radical Biol. Med. · 2012 · 53 · 28010.1016/j.freeradbiomed.2012.04.034 ↗
44. Soenen · Contrast Media Mol. Imaging · 2009 · 4 · 20710.1002/cmmi.282 ↗
45. Hentze · Cell · 2004 · 117 · 28510.1016/S0092-8674(04)00343-5 ↗
46. Taylor · Cancer Res. · 1978 · 38 · 2745
47. Trump · Am. J. Pathol. · 1973 · 72 · 295
48. Mahmoudi · ACS Nano · 2011 · 5 · 726310.1021/nn2021088 ↗
49. Nnebe · J. Colloid Interface Sci. · 2004 · 276 · 30610.1016/j.jcis.2004.03.065 ↗
50. Lunov · Biomaterials · 2010 · 31 · 506310.1016/j.biomaterials.2010.03.023 ↗
51. Hsiao · NMR Biomed. · 2008 · 21 · 82010.1002/nbm.1260 ↗
52. Vu-Quang · Acta Biomater. · 2011 · 7 · 393510.1016/j.actbio.2011.06.044 ↗
53. Li · Theranostics · 2012 · 2 · 7610.7150/thno.3462 ↗
54. Kostova · Eur. J. Med. Chem. · 2006 · 41 · 71710.1016/j.ejmech.2006.03.020 ↗
55. Soma · J. Controlled Release · 2000 · 68 · 28310.1016/S0168-3659(00)00269-8 ↗
56. Arbab · Radiology · 2003 · 229 · 83810.1148/radiol.2293021215 ↗
57. Cairo · Biochem. Biophys. Res. Commun. · 1985 · 133 · 31410.1016/0006-291X(85)91877-7 ↗
58. Recalcati · Blood · 1998 · 91 · 105910.1182/blood.V91.3.1059 ↗
59. Hoskins · J. Nanobiotechnol. · 2012 · 10 · 1510.1186/1477-3155-10-15 ↗
60. Tromsdorf · Nano Lett. · 2007 · 7 · 242210.1021/nl071099b ↗